LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint
出版年份 2019 全文链接
标题
LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 10, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-30
DOI
10.1038/s41419-019-1886-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC
- (2019) Chen-Chen Zhao et al. Cell Death & Disease
- KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer
- (2019) Yinzhu Bian et al. CANCER BIOLOGY & THERAPY
- Rosiglitazone Improves Glucocorticoid Resistance in a Sudden Sensorineural Hearing Loss by Promoting MAP Kinase Phosphatase-1 Expression
- (2019) Liang Xia et al. MEDIATORS OF INFLAMMATION
- Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer
- (2019) Jessica Konen et al. Cancers
- Oestrogen-deficiency induces bone loss by modulating CD14+ monocyte and CD4+ T cell DR3 expression and serum TL1A levels
- (2019) Fraser L. Collins et al. BMC MUSCULOSKELETAL DISORDERS
- MiR-216a-5p targets TCTN1 to inhibit cell proliferation and induce apoptosis in esophageal squamous cell carcinoma
- (2019) Lixun Chai et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p
- (2019) Kai Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- TGF-β2 Induces Gli1 in a Smad3-Dependent Manner Against Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats
- (2019) Li Peng et al. Frontiers in Neuroscience
- miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway
- (2018) Nan Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis
- (2018) Zhao Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation
- (2018) Huaying Dong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
- (2018) Huaying Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation
- (2018) Di Cheng et al. EBioMedicine
- Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
- (2018) Jun Zhang et al. Frontiers in Oncology
- LncRNA ZEB1-AS1/miR-409–3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer
- (2018) Ruize Qu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts
- (2018) Elham Abedini Bakhshmand et al. BIOLOGICAL CHEMISTRY
- YAP1-induced MALAT1 promotes epithelial–mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer
- (2018) Zhenqiang Sun et al. ONCOGENE
- Antitumor immunity is defective in T cell–specific microRNA-155–deficient mice and is rescued by immune checkpoint blockade
- (2017) Thomas B. Huffaker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer
- (2017) Wenjing Su et al. Molecular Cancer
- ZEB1-regulated inflammatory phenotype in breast cancer cells
- (2017) Akihiro Katsura et al. Molecular Oncology
- HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a
- (2017) Qinghua Wang et al. OncoTargets and Therapy
- Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway
- (2017) Yun Cui et al. Oncotarget
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade
- (2017) Haoran Zha et al. OncoImmunology
- The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
- (2017) Muhammad Zaeem Noman et al. OncoImmunology
- Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment
- (2016) Stefani Spranger INTERNATIONAL IMMUNOLOGY
- Elevated RNA expression of long non-coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma
- (2016) YULING YAN et al. Molecular Medicine Reports
- Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer
- (2016) Ruth J. Davis et al. ORAL ONCOLOGY
- Novel immunotherapies in lymphoid malignancies
- (2015) Connie Lee Batlevi et al. Nature Reviews Clinical Oncology
- Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer
- (2015) Peng Wang et al. NUCLEIC ACIDS RESEARCH
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
- (2015) Annie A Wu et al. OncoImmunology
- LIPCAR
- (2014) Gerald W. Dorn CIRCULATION RESEARCH
- LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
- (2014) Jiagen Li et al. GUT
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma
- (2012) Siria Lemma et al. HISTOPATHOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
- (2011) A Smith et al. BRITISH JOURNAL OF CANCER
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
- (2011) Leonardo Salmena et al. CELL
- The Emergence of lncRNAs in Cancer Biology
- (2011) J. R. Prensner et al. Cancer Discovery
- siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells
- (2010) W. Hobo et al. BLOOD
- ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
- (2010) E Sánchez-Tilló et al. ONCOGENE
- Getting to the Root of miRNA-Mediated Gene Silencing
- (2008) Ana Eulalio et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now